Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TQB3804 |
Trade Name | |
Synonyms | TQB 3804|TQB-3804|EGFR-IN-7 |
Drug Descriptions |
TQB3804 (EGFR-IN-7) is a 4th generation EGFR inhibitor that demonstrates activity against EGFR TKI resistance mutations, and may lead to anti-tumor effect (Proceedings of the American Association for Cancer Research, Vol 60, Mar 2019, Abstract #1320). |
DrugClasses | EGFR Inhibitor (Pan) 61 |
CAS Registry Number | 2267329-76-8 |
NCIT ID | C173415 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TQB3804 | TQB3804 | 0 | 0 |